Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients.
Launched by AGA KHAN UNIVERSITY · Aug 9, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different tools used to help doctors place a breathing tube in patients undergoing thoracic (chest) surgery. The two devices being compared are the McGrath laryngoscope and the Macintosh laryngoscope. The main goals are to find out which device allows doctors to successfully place the tube on the first try and how long it takes to do so with each device.
To participate in this study, you should be between 18 and 65 years old and scheduled for elective thoracic surgery that requires one lung to be temporarily out of service. However, if you have certain conditions, like a history of difficult intubation or a recent respiratory infection, you may not be eligible. If you choose to take part, you'll be placed in one of two groups: one using the Macintosh device and the other using the McGrath device. This research aims to improve patient care by determining which method is more effective for patients needing this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-65 years
- • American Society of Anaesthesiologists physical status (ASA) I, II, III
- • Elective thoracic surgery patients, requiring one lung ventilation.
- Exclusion Criteria:
- • Patients requiring rapid sequence induction
- • Patients with a structural problem in the airway on chest radiography
- • History of difficult intubation
- • Planned tracheostomy \\ the presence of a tracheostomy
- • Patients with a BMI \>35 kg\\m2. Who at risk of regurgitation\\ Aspiration
- • Anticipated Difficult Airway (Mallampati IV)
- • Pre-existing sore throat or hoarseness, or recent respiratory infection (\<15 days)
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported